chr19-49665831-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001571.6(IRF3):c.-209C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,590,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001571.6 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF3 | NM_001571.6 | c.-209C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/8 | ENST00000377139.8 | NP_001562.1 | ||
IRF3 | NM_001571.6 | c.-209C>T | 5_prime_UTR_variant | 1/8 | ENST00000377139.8 | NP_001562.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF3 | ENST00000377139.8 | c.-209C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/8 | 1 | NM_001571.6 | ENSP00000366344.3 | |||
IRF3 | ENST00000377139.8 | c.-209C>T | 5_prime_UTR_variant | 1/8 | 1 | NM_001571.6 | ENSP00000366344.3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248650Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134884
GnomAD4 exome AF: 0.00000695 AC: 10AN: 1437872Hom.: 0 Cov.: 32 AF XY: 0.00000704 AC XY: 5AN XY: 709914
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2024 | The c.8G>A (p.R3Q) alteration is located in exon 1 (coding exon 1) of the BCL2L12 gene. This alteration results from a G to A substitution at nucleotide position 8, causing the arginine (R) at amino acid position 3 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at